Inventor · disambiguated record
Bernard Maillere
Also filed as: MAILLERE BERNARD
8 granted patents·11 pending applications·27 citations·filing 2000–2020
80Inventor score
Files withCOMMISSARIAT ENERGIE ATOMIQUE8MAILLERE BERNARD2BALL SIMON1COMMISSARIAT A I EN ATOMIQUE1COMMISSARIAT A I'ENERGIE ATOMIQUE1
Top patents by PatentIndex Score
19 records- 0176US7488791B2Mixture of peptides derived from E6 and/or E7 papillomavirus proteins and uses thereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2002·Granted Feb 10, 2009·12 cites·10 claims
- 0273US6649166B1Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing sameCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2000·Granted Nov 18, 2003·12 cites·13 claims
- 0365US9687539B2CD4+ T survivin epitopes and uses thereofCOMMISSARIAT A I'ENERGIE ATOMIQUE·Filed 2014·Granted Jun 27, 2017·3 cites·15 claims
- 0462US8715680B2HLA peptide therapyBALL SIMON·Filed 2007·Granted May 6, 2014·0 cites·5 claims
- 0557US2014295550A1Hla peptide therapyUNIV BIRMINGHAM·Filed 2014·Application pending·0 cites
- 0652US2010203080A1Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses ThereofCOMMISSARIAT A I EN ATOMIQUE·Filed 2008·Application pending·0 cites
- 0749US2023142800A1Adalimumab Variants with Reduced Immunogenic PotentialCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2020·Application pending·0 cites
- 0847US2011275098A1Method for Evaluating The Immunogenicity of ProteinsMAILLERE BERNARD·Filed 2009·Application pending·0 cites
- 0945US2009004214A1Cd4+ Survivin Epitopes and Uses ThereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2006·Application pending·0 cites
- 1043US9758552B2HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathwayCOMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT·Filed 2013·Granted Sep 12, 2017·0 cites·14 claims
- 1140US2010324829A1Method of selecting hla-dp4 ligands and the applications thereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2010·Application pending·0 cites
- 1239US7718575B2Method of selecting HLA-DP4 ligands and the applications thereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2002·Granted May 18, 2010·0 cites·12 claims
- 1338US2016257727A1Immunogenic peptides of the cyclin b1 tumor antigenCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2014·Application pending·0 cites
- 1437US2011159022A1Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer VaccineKERZERHO JEROME·Filed 2009·Application pending·0 cites
- 1536US10550166B2Immunogenic peptides of the cyclin B1 tumor antigenCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2017·Granted Feb 4, 2020·0 cites·16 claims
- 1636US9841429B2Method for real-time measurement of the individual secretions of a cellLIVACHE THIERRY·Filed 2012·Granted Dec 12, 2017·0 cites·19 claims
- 1735US2006110401A1Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereofMAILLERE BERNARD·Filed 2003·Application pending·0 cites
- 1833US2004115622A1Mixture of peptides originating from a Nef protein and applications thereofFiled 2002·Application pending·0 cites
- 1932US2009130134A1T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereofPANCRE VERONIQUE·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bernard Maillere files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →